Alanazi, A.Z.; Alhazzani, K.; Alrewily, S.Q.; Aljerian, K.; Algahtani, M.M.; Alqahtani, Q.H.; Haspula, D.; Alhamed, A.S.; Alqinyah, M.; Raish, M.
The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity. Pharmaceuticals 2023, 16, 921.
https://doi.org/10.3390/ph16070921
AMA Style
Alanazi AZ, Alhazzani K, Alrewily SQ, Aljerian K, Algahtani MM, Alqahtani QH, Haspula D, Alhamed AS, Alqinyah M, Raish M.
The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity. Pharmaceuticals. 2023; 16(7):921.
https://doi.org/10.3390/ph16070921
Chicago/Turabian Style
Alanazi, Ahmed Z., Khalid Alhazzani, Salah Q. Alrewily, Khaldoon Aljerian, Mohammad M. Algahtani, Qamraa H. Alqahtani, Dhanush Haspula, Abdullah S. Alhamed, Mohammed Alqinyah, and Mohammad Raish.
2023. "The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity" Pharmaceuticals 16, no. 7: 921.
https://doi.org/10.3390/ph16070921
APA Style
Alanazi, A. Z., Alhazzani, K., Alrewily, S. Q., Aljerian, K., Algahtani, M. M., Alqahtani, Q. H., Haspula, D., Alhamed, A. S., Alqinyah, M., & Raish, M.
(2023). The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity. Pharmaceuticals, 16(7), 921.
https://doi.org/10.3390/ph16070921
